Low‑Level Laser Therapy with 670 nm Alleviates Diabetic Retinopathy in an Experimental Model

To evaluate the effects of low‑level laser therapy (LLLT) on the retina with diabetic retinopathy (DR).

Eight Wistar rats were used as a control group, and 64 rats were injected intraperitoneally with 55 mg/kg of streptozotocin to induce diabetes and served as a diabetic group. After the establishment of the DR, the rats were separated into (a) 32 rats with DR; did not receive any treatment,(b) 32 rats with DR were exposed to 670 nm LLLT for 6 successive weeks(2 sessions/week). The retinal protein was analyzed by sodium dodecyl sulfate‑polyacrylamide gel electrophoresis, total antioxidant capacity (TAC), hydrogen peroxide (H2 O2 ), and histological examination.

LLLT improved retinal proteins such as neurofilament (NF) proteins (200 KDa, 160 KDa, and 86 KDa), neuron‑specific enolase (NSE) (46 KDa). Moreover, the percentage changes in TAC were 46.8% (P < 0.001), 14.5% (P < 0.01), 4.8% and 1.6% (P ˃ 0.05), and in H2 O2, they were 30% (P < 0.001), 25% (P < 0.001), 20% (P < 0.01), and 5% (P ˃ 0.05) after 1, 2, 4, and 6 weeks, compared with the control. DR displayed swelling and disorganization in the retinal ganglion cells(RGCs) and photoreceptors, congestion of the capillaries in the nerve fiber layer, thickening of the endothelial cells’ capillaries, and edema of the outer segment of the photoreceptors layer. The improvement of the retinal structure was achieved after LLLT.

LLLT could modulate retinal proteins such as NSE and NFs, improve the RGCs, photoreceptors, and reduce the oxidative stress that originated in the retina from diabetes‑induced DR